Hep AD38 Assay
Approximately 5% of the world’s population has been infected with hepatitis B virus (HBV). Ten percent of these adults will become chronic carriers, as will 95% of the infants infected perinatally. Those that do become chronically infected with HBV are at increased risk of developing liver dysfunction, cirrhosis, and liver failure (1). In addition, they also have a greater incidence of heptocellular carcinoma (2). Approximately two million chronic carriers die annually from liver disease attributed to infection by HBV (3).
KeywordsSaline Sodium Citrate Reporter Lysis Buffer Multichannel Pipeter Develop Liver Dysfunction Chroma Spin
- 2.Beasley, R. P. and Hwang, L.-Y. (1994) Epidemiology of heptocellular carcinoma, in Viral Hepatitis and Liver Disease (Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H., eds.), Grune & Stratton, New York, pp. 209–224.Google Scholar
- 3.World Health Organization (1990) WHO reports decry of neglect of world health problems. ASM News 56, 358,359.Google Scholar
- 4.Seeger, C., Summers, J., and Mason, W. S. (1991) Viral DNA synthesis, in Current Topics in Microbiology and Immunology, vol. 168. Springer-Verlag, Berlin,pp. 41–66.Google Scholar
- 9.Ladner, S. K., Otto, M. J., Barker, C. S., Zaifert, K., Wang, G.-H., Guo, J.-T., Seeger, C., and King, R. W. (1997) Inducible expression of human hepatitis B virus in stably transfected hepatoblastoma cell: a novel system for screening potential inhibitors of HBV replication, submitted for publication.Google Scholar
- 10.Current Protocols in Molecular Biology, vol. 3 (1995) (Janssen, K., series ed.), Wiley, New York, pp. A.2.5.Google Scholar